These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7990710)

  • 1. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus.
    Kelley D; Mokan M; Veneman T
    Metabolism; 1994 Dec; 43(12):1549-57. PubMed ID: 7990710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.
    Kelley DE; Simoneau JA
    J Clin Invest; 1994 Dec; 94(6):2349-56. PubMed ID: 7989591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
    McMahon M; Marsh HM; Rizza RA
    Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.
    Mitrakou A; Kelley D; Veneman T; Jenssen T; Pangburn T; Reilly J; Gerich J
    Diabetes; 1990 Nov; 39(11):1381-90. PubMed ID: 2121568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.
    Thorburn AW; Gumbiner B; Bulacan F; Wallace P; Henry RR
    J Clin Invest; 1990 Feb; 85(2):522-9. PubMed ID: 2105341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues.
    Firth RG; Bell PM; Marsh HM; Hansen I; Rizza RA
    J Clin Invest; 1986 May; 77(5):1525-32. PubMed ID: 3517067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients.
    Butler PC; Rizza RA
    Diabetes; 1991 Jan; 40(1):73-81. PubMed ID: 2015976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
    Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
    Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.
    Woerle HJ; Szoke E; Meyer C; Dostou JM; Wittlin SD; Gosmanov NR; Welle SL; Gerich JE
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E67-E77. PubMed ID: 16105859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
    Mandarino LJ; Consoli A; Jain A; Kelley DE
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration.
    Katz H; Homan M; Jensen M; Caumo A; Cobelli C; Rizza R
    Diabetes; 1994 Feb; 43(2):289-96. PubMed ID: 8288053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
    Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
    Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism.
    Consoli A; Nurjhan N; Reilly JJ; Bier DM; Gerich JE
    J Clin Invest; 1990 Dec; 86(6):2038-45. PubMed ID: 2254458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals.
    Avogaro A; Toffolo G; Miola M; Valerio A; Tiengo A; Cobelli C; Del Prato S
    J Clin Invest; 1996 Jul; 98(1):108-15. PubMed ID: 8690781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus.
    Ludvik B; Nolan JJ; Roberts A; Baloga J; Joyce M; Bell JM; Olefsky JM
    J Clin Invest; 1997 Nov; 100(9):2354-61. PubMed ID: 9410915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular defects in glucose metabolism in obese patients with NIDDM.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDM.
    Henry RR; Gumbiner B; Flynn T; Thorburn AW
    Diabetes; 1990 Feb; 39(2):149-56. PubMed ID: 2227122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
    Luzi L; Petrides AS; De Fronzo RA
    Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM.
    Wright KS; Beck-Nielsen H; Kolterman OG; Mandarino LJ
    Diabetes; 1988 Apr; 37(4):436-40. PubMed ID: 2837418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.